PGD is a technology used in in vitro fertilisation (IVF) genetic testing that aids in looking deeper into embryos than their outward appearance. By completing embryo genetic testing, PGD considerably lowers the likelihood of generating abnormal embryos, which is a key element in the market’s expansion. Additionally, it raises the likelihood of healthy, fruitful pregnancies. Additionally, factors including rising stress levels, increased drug and alcohol use, increased smoking, poor food, and environmental contaminants as well as an increase in hormone-related health issues have led to an increase in infertility cases worldwide. This has increased the demand for IVF, which has helped the industry expand. Additionally, benefits including the creation of “saviour siblings” and the increased adoption of assisted reproductive technology (ART) in underdeveloped nations are anticipated to present the PGD industry with lucrative growth potential. Preimplantation genetics diagnostic market size is growing due to the rise in fatal genetic, hereditary, and chromosomal illnesses like Duchenne muscular dystrophy, down syndrome, cystic fibrosis, triploidy, and thalassemia that motivate patients to choose PGD.
330,773 ART cycles were carried out across 448 reporting clinics in 2019, according to the Centers for Disease Control and Prevention (CDC), and 77,998 live births were the outcome. Additionally, over the past ten years, the use of ART has nearly increased, accounting for around 2.1% of all children born in the United States annually. Furthermore, pre-implantation genetic diagnostics for monogenic or single-gene disorders (PGT-M) can be utilised to prevent more than 600 genetic diseases, according to the Human Fertilization and Embryology Authority, UK. Additionally, the fertility rate in Canada dropped from 1.47 children per woman in 2019 to a record-low 1.40 children per woman in 2020, according to Statics Canada. Additionally, Canada’s birth rate decreased by 3.6% in 2020, the largest decline since 2006. The country also registered the fewest births since 2006. Numerous nations around the world are seeing a decline in fertility rates. These elements have a beneficial impact on the market share for preimplantation genetics diagnosis.
The new coronavirus has rapidly spread over a number of nations and regions, having a profound effect on both individual lives and the community as a whole. It started off as a human health issue and is now a serious threat to international trade, the economy, and the financial system. The COVID-19 pandemic raised the need for public healthcare facilities, which led to an increase in global healthcare spending.
